Showing results (121-130 of 258) with videos related to

Sort By:
Pageof 26
Cancer Immunology, Immunotherapy : CII|December 18, 2025
Immune biomarkers for head and neck cancerNavid Sobhani, Alberto D'Angelo, Fernanda G Kugeratski, et al.
Pharmaceuticals (Basel, Switzerland)|March 6, 2021
Tumor Type Agnostic Therapy Carrying BRAF Mutation: Case Reports and Review of LiteratureOttavia Bernocchi, Marianna Sirico, Silvia Paola Corona, et al.
Expert Review of Gastroenterology & Hepatology|July 5, 2016
Apatinib for the treatment of gastric cancerGiandomenico Roviello, Andrea Ravelli, Anna Ida Fiaschi, et al.
Future Oncology (London, England)|February 13, 2015
Eribulin in heavily pretreated metastatic breast cancer patients and clinical/biological feature correlations: impact on the practiceAlessandra Fabi, Luca Moscetti, Mariangela Ciccarese, et al.
Plos One|July 5, 2013
Triple negative breast cancers have a reduced expression of DNA repair genesEnilze Ribeiro, Monica Ganzinelli, Daniele Andreis, et al.
British Journal of Cancer|November 28, 2018
Early immune modulation by single-agent trastuzumab as a marker of trastuzumab benefitTiziana Triulzi, Viola Regondi, Loris De Cecco, et al.
Expert Review of Anticancer Therapy|May 1, 2015
Immune-related strategies driving immunotherapy in breast cancer treatment: a real clinical opportunityAndrea Ravelli, James M Reuben, Francesco Lanza, et al.
Medical Oncology (Northwood, London, England)|July 31, 2015
Ibrutinib: from bench side to clinical implicationsDavide Grisafi, Alessandra Maestro, Camilla Grumi, et al.
Pageof 26